Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma

MLA

Gillian Mahy, et al. “Malignant Range Elevation of Serum Chromogranin A Due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma.” Case Reports in Endocrinology, vol. 2011, Jan. 2011, pp. 1–3. EBSCOhost, https://doi.org/10.1155/2011/342480.

APA

Gillian Mahy, Kunwarjit S. Sangla, Usman H. Malabu, & Rozemary Karamatic. (2011). Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. Case Reports in Endocrinology, 2011, 1–3. https://doi.org/10.1155/2011/342480

Chicago

Gillian Mahy, Kunwarjit S. Sangla, Usman H. Malabu, and Rozemary Karamatic. 2011. “Malignant Range Elevation of Serum Chromogranin A Due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma.” Case Reports in Endocrinology 2011 (January): 1–3. doi:10.1155/2011/342480.